CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −1,078 | $65.20 | $70K | 711 |
| 2023-05-31 | Malecek Michael J Chief Legal Officer | Sale 10b5-1 | −711 | $65.98 | $47K | 0 |
| 2023-05-31 | Malecek Michael J Chief Legal Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 110,000 | ||
| 2023-05-19 | Walker Karin L Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | $15.04 | $75K | 5,000 |
| 2023-05-19 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −2,823 | $73.63 | $208K | 2,177 |
| 2023-05-19 | Walker Karin L Chief Accounting Officer | Sale 10b5-1 | −2,177 | $74.47 | $162K | 0 |
| 2023-05-19 | Walker Karin L Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 20,481 | ||
| 2023-05-17 | Cooke Shane Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | Cobb Paula K Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | COLLIER RICHARD T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | Dunn William H. Jr. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-05-17 | Ekman Lars Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | Harfstrand Karl Anders Olof Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | Kim Helen Susan Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | Selkoe Dennis J. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2023-05-17 | Kinney Gene G. President and CEO | Option exercise 10b5-1 | +45,000 | $29.81 | $1.3M | 57,793 |
| 2023-05-17 | Kinney Gene G. President and CEO | Sale 10b5-1 | −10,202 | $72.70 | $742K | 47,591 |
| 2023-05-17 | Kinney Gene G. President and CEO | Sale 10b5-1 | −19,864 | $73.60 | $1.5M | 27,727 |
| 2023-05-17 | Kinney Gene G. President and CEO | Sale 10b5-1 | −14,934 | $74.49 | $1.1M | 12,793 |
| 2023-05-17 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,000 | 0 |
Page 14 of 28 · 555 trades